• Bluejay Diagnostics will implement a 1-for-4 reverse stock split effective at 12:01 a.m. Eastern Time on November 3, 2026.
• Split-adjusted trading on the Nasdaq Capital Market begins November 3 under the existing symbol BJDX.
• Outstanding common shares will fall from approximately 4,468,051 to approximately 1,117,013.
• Common shares issuable upon exercise of prefunded warrants will decrease from 222,581 to 55,645.
• Fractional shares will be paid in cash rather than issued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610301030ACCESSWRNAPR_____1244233) on October 30, 2026, and is solely responsible for the information contained therein.